Please assess the completion status of the following clinical trial:

Trial Title: Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient Setting

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Inpatients, who received IV treatment (bolus administration) with cafedrine/theodrenaline or ephedrine (Ephedrin Meduna) due to an acute arterial hypotension~* Consent to use of data is available~* Patient under careful blood pressure and pulse monitoring (at least 2 minutes measuring interval (BP/HR) and/or at least 7 measurements within the first 15 minutes after the first application of cafedrine/theodrenaline or ephedrine)~Cohort A:~* Treatment of hypotension in \< 100 mm Hg syst. and/or drop in blood pressure \> 20% syst. compared to preoperative base value (syst.)~* Patients ≥ 50 years old~* Pre-existing comorbidities (ASA classification 2-4)~* Elective surgery~* General anaesthesia with propofol/fentanyl ≥ 0.2 mg (or equivalent)~Cohort B:~* Treatment of hypotension in \< 100 mm Hg syst. and/or drop in blood pressure \> 10% syst. compared to preoperative base value (syst.)~* Patients ≥ 18 years old~* Caesarean section under spinal anaesthesia~Exclusion Criteria:~* Contraindication to the use of cafedrine/theodrenaline or ephedrine (Ephedrin Meduna) in accordance with current German specialist information~  * Hypersensitivity to any product ingredient~ * Hypertensive blood pressure readings~ * Mitral stenosis~ * Narrow-angle glaucoma~ * Hyperthyroidism~ * Pheochromocytoma~ * Prostatic adenoma with urinary retention~ * Bronchial asthmatics with sulphite sensitivity~ * Hyper-excitability~ * Arteriosclerosis~ * Aneurysm~ * Treatment with other indirect sympathomimetic drugs (Example: phenylpropanolamine, phenylephrine, pseudoephedrine or methylphenidate)~ * Use of Monoamine oxidase (MAO) inhibitors (including within the last two weeks)~* Prophylactic administration of cafedrine/theodrenaline or ephedrine or other anti-hypertensives~* Sepsis, septic shock or systemic inflammatory response syndrome (SIRS)~Cohort A:~• Intra-cranial surgery or heart surgery~Cohort B:~* High-risk pregnancy (emergency Caesarean, severe infantile malformation)~* Multiple pregnancy~* Amniotic infection syndrome

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Cohort A (Type: None): Patients ≥ 50 years old, with pre-existing comorbidities, who receive general anaesthesia
- Cohort B (Type: None): Patients, who undergo caesarean section under spinal anaesthesia

Based on this trial design, predict the completion outcome and termination type (if applicable).